Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.54 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
News headline image
Airbnb To Rally Around 59%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Keybanc raised the price target for Intuit Inc. (NASDAQ: INTU) from $450 to $475. Keybanc analyst Josh Beck maintained an Overweight rating. Intuit shares fell 1.8% to close at $419.33 on Tuesday. 
Via Benzinga
News headline image
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run ↗
Viking Therapeutics stock might in the midst of a historic run. 
Via The Motley Fool
News headline image
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%? ↗
Viking could have a strong rival to Novo Nordisk's Wegovy and Ozempic and Lilly's Mounjaro in the making. 
Via The Motley Fool
News headline image
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says ↗
Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735. 
Via Benzinga
News headline image
Viking Therapeutics Steps Into The Obesity Ring — And Catapults 63% ↗
The company is taking on rivals Novo Nordisk, Eli Lilly and Amgen. 
Via Investor's Business Daily
News headline image
4 Analysts Have This to Say About Viking Therapeutics ↗
 
Via Benzinga
News headline image
2 Surging Healthcare Stocks That Are Still Worth Buying ↗
These two NASH drugmakers have a lot of room to run. 
Via The Motley Fool
News headline image
Viking Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
Viking Therapeutics Inc. (NASDAQ: VKTX) Records 52-Week High Tuesday Morning
Via Investor Brand Network
News headline image
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP 
Via MarketBeat
News headline image
Dow Rises 50 Points; Harmony Biosciences Shares Plunge ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also... 
Via Benzinga
News headline image
Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.01% to 32,436.22 while the NASDAQ fell... 
Via Benzinga
News headline image
Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today? ↗
Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Viking Therapeutics (VKTX) Stock Up 38% Today? ↗
Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735. 
Via InvestorPlace
News headline image
Why Viking Therapeutics Stock Is Soaring Tuesday ↗
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! 
Via InvestorPlace
News headline image
Is Viking Therapeutics a Smart Buy on the Dip? ↗
The stock recently fell around 25% for reasons that had nothing to do with its lead program. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗
 
Via Benzinga
News headline image
Analyzing Viking Therapeutics's Short Interest ↗
Viking Therapeutics's (NASDAQ:VKTX) short percent of float has risen 7.17% since its last report. The company recently reported that it has 1.89 million shares sold short, which is 2.54% of all regular... 
Via Benzinga
News headline image
5 Most Expensive Health Care Stocks You Should Worry About ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023 ↗
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results. 
Via The Motley Fool
News headline image
Why Did Viking Therapeutics Stock Skyrocket
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. 
Via MarketBeat
News headline image
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.